{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:47:03Z","timestamp":1792100823511,"version":"4.4.0"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W014122\/1"],"award-info":[{"award-number":["MR\/W014122\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heartburn Cancer UK","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["41162"],"award-info":[{"award-number":["41162"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["41162"],"award-info":[{"award-number":["41162"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cambridge Experimental Cancer Medicine Centre","award":["C96\/A25177\/RG86728"],"award-info":[{"award-number":["C96\/A25177\/RG86728"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Offering individuals with gastro-oesophageal reflux a non-endoscopic capsule sponge test increased detection of Barrett\u2019s oesophagus (BO), a precursor to oesophageal adenocarcinoma. However, only 24% of individuals identified through general practitioner (GP) records participated. We therefore performed an implementation study to assess the feasibility of screening on a mobile unit and screening uptake among GP-invited and self-referred individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this implementation study, 3293 individuals aged \u226550 with a repeat proton pump inhibitor prescription were invited to participate by their GPs across three GP practices in the East of England between June 2021 and January 2023. Additionally, we advertised the study and allowed self-referrals. Eligibility was assessed based on age and reflux history. Eligible individuals were invited to an appointment. Acceptability was assessed after the appointment. Individuals with a positive capsule sponge test were referred for endoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Half of the GP-invited individuals responded, of whom 59.6% (n=952\/1598) were interested. Among interested individuals who could be contacted, 66.3% (n=574\/866) were eligible, and 532 participated. Of these, 502 (94%) successfully swallowed a capsule sponge, representing 15% of those invited and 87.5% of eligible individuals. Among 468 individuals who self-referred and could be contacted, 48.5% (n=227) were eligible, 217 participated, and 208 (96%) successfully swallowed a capsule sponge (39.6% of self-referred, 91.6% of eligible individuals). 9.4% (n=47\/502) of GP-invited and 12.0% (n=25\/208) of self-referred individuals were referred for endoscopy, with 4.2% (n=21\/502) and 3.4% (n=7\/208), respectively, diagnosed with BO (positive predictive value of endoscopy referral=42.4%), including three with dysplasia. Over 99% of participants said the capsule sponge test was acceptable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Screening on a mobile unit is feasible. Identifying individuals at increased risk of BO from GP records is feasible, and encouraging self-referrals increases uptake. BO prevalence was similar among eligible participants who self-referred and those identified through GP records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN91655550\">ISRCTN91655550<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2026-002496","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:25:30Z","timestamp":1790101530000},"page":"e002496","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Using a mobile unit to deliver capsule sponge testing for Barrett\u2019s oesophagus in the community in England through GP invitation and self-referral: an implementation study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"isrctn91655550","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-4820","authenticated-orcid":false,"given":"Rebecca","family":"Landy","sequence":"first","affiliation":[{"name":"Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK"},{"name":"Surveillance, Prevention, & Health Services Research, American Cancer Society, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4025-9132","authenticated-orcid":false,"given":"Jo","family":"Waller","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK"},{"name":"Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Debiram-Beecham","sequence":"additional","affiliation":[{"name":"Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, UK"},{"name":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Kerridge","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK"},{"name":"Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Booth","sequence":"additional","affiliation":[{"name":"Melbourne House Surgery, Parkside Medical Centre, Chelmsford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holloway","sequence":"additional","affiliation":[{"name":"East of England Cancer Alliance, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Morrow","sequence":"additional","affiliation":[{"name":"Granta Medical Practices, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M","family":"Walter","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK"},{"name":"The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"McCord","sequence":"additional","affiliation":[{"name":"Heartburn Cancer UK, Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D","family":"Sasieni","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK"},{"name":"Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, UK"},{"name":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stovin","sequence":"additional","affiliation":[{"name":"Macmillan GP, Cambridge and Peterborough CCG, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026092211251905000_13.1.e002496.1","unstructured":"Cancer Research UK . Oesophageal cancer statistics. n.d. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/oesophageal-cancer"},{"key":"2026092211251905000_13.1.e002496.2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010141","article-title":"Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026092211251905000_13.1.e002496.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"2026092211251905000_13.1.e002496.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp012118"},{"key":"2026092211251905000_13.1.e002496.5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(20)31099-0","article-title":"Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial","volume":"396","author":"Fitzgerald","year":"2020","journal-title":"The Lancet"},{"key":"2026092211251905000_13.1.e002496.6","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.322"},{"key":"2026092211251905000_13.1.e002496.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308865"},{"key":"2026092211251905000_13.1.e002496.8","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.58","article-title":"Surveillance in patients with Barrett\u2019s esophagus for early detection of esophageal adenocarcinoma: a systematic review and meta-analysis","volume":"6","author":"Qiao","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"2026092211251905000_13.1.e002496.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2012.35"},{"key":"2026092211251905000_13.1.e002496.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305372"},{"key":"2026092211251905000_13.1.e002496.11","unstructured":"National Institute for Health and Care Excellence . Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Clinical Guideline CG184 2019."},{"key":"2026092211251905000_13.1.e002496.12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2468-1253(16)30118-2","article-title":"Risk stratification of Barrett\u2019s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study","volume":"2","author":"Ross-Innes","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026092211251905000_13.1.e002496.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4372","article-title":"Acceptability and accuracy of a non-endoscopic screening test for Barrett\u2019s oesophagus in primary care: cohort study","volume":"341","author":"Kadri","year":"2010","journal-title":"BMJ"},{"key":"2026092211251905000_13.1.e002496.14","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001210"},{"key":"2026092211251905000_13.1.e002496.15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cgh.2018.07.043","article-title":"Safety and acceptability of esophageal Cytosponge cell collection device in a pooled analysis of data from individual patients","volume":"17","author":"Januszewicz","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092211251905000_13.1.e002496.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013901","article-title":"Acceptability of the Cytosponge procedure for detecting Barrett\u2019s oesophagus: a qualitative study","volume":"7","author":"Freeman","year":"2017","journal-title":"BMJ Open"},{"key":"2026092211251905000_13.1.e002496.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054258","article-title":"Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial","volume":"12","author":"Maroni","year":"2022","journal-title":"BMJ Open"},{"key":"2026092211251905000_13.1.e002496.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001780","article-title":"Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett\u2019s esophagus: a multi-center case-control study","volume":"12","author":"Ross-Innes","year":"2015","journal-title":"PLoS Med"},{"key":"2026092211251905000_13.1.e002496.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037075","article-title":"Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk","volume":"10","author":"Crosbie","year":"2020","journal-title":"BMJ Open"},{"key":"2026092211251905000_13.1.e002496.20","unstructured":"Ministry of Housing Communities & Local Government . English indices of deprivation 2019. Available: https:\/\/imd-by-postcode.opendatacommunities.org\/imd\/2019 [Accessed 27 May 2025]."},{"key":"2026092211251905000_13.1.e002496.21","doi-asserted-by":"publisher","DOI":"10.2307\/2276774"},{"key":"2026092211251905000_13.1.e002496.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i6795","article-title":"Standards for Reporting Implementation Studies (StaRI) Statement","volume":"356","author":"Pinnock","year":"2017","journal-title":"BMJ"},{"key":"2026092211251905000_13.1.e002496.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013318","article-title":"Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document","volume":"7","author":"Pinnock","year":"2017","journal-title":"BMJ Open"},{"key":"2026092211251905000_13.1.e002496.24","doi-asserted-by":"publisher","DOI":"10.3310\/hta20220"},{"key":"2026092211251905000_13.1.e002496.25","unstructured":"Moss R , Herbert P , Stewart J , et al . Capsule sponge cell collection devices for the detection of pre-malignant (barrett\u2019s oesophagus) or early stage oesophageal cancer. 2023. Available: https:\/\/shtg.scot\/our-advice\/community-based-respiratory-care-services-for-patients-with-chronic-respiratory-conditions\/"},{"key":"2026092211251905000_13.1.e002496.26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/apt.18472","article-title":"Use of a non-endoscopic capsule-sponge triage test for reflux symptoms: results from the NHS England prospective real-world evaluation","volume":"61","author":"Gourgiotis","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092211251905000_13.1.e002496.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6947.102"},{"key":"2026092211251905000_13.1.e002496.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100969","article-title":"Economic evaluation of Cytosponge-trefoil factor 3 for Barrett esophagus: a cost-utility analysis of randomised controlled trial data","volume":"37","author":"Swart","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026092211251905000_13.1.e002496.29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cgh.2017.02.017","article-title":"Cost effectiveness of screening patients with gastroesophageal reflux disease for Barrett\u2019s esophagus with a minimally invasive cell sampling device","volume":"15","author":"Heberle","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092211251905000_13.1.e002496.30","unstructured":"National Institute for Health and Care Excellence (NICE) . NICE cks: gastrointestinal tract (upper) cancers\u2014 - recognition and referral. 2025. Available: https:\/\/cks.nice.org.uk\/topics\/gastrointestinal-tract-upper-cancers-recognition-referral\/#topic-menu"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2026-002496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:25:35Z","timestamp":1790101535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2026-002496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,22]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjgast-2026-002496"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2026-002496","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}